İntravenöz Trombolitik Tedavi Verilen Akut İskemik İnmeli Hastaların Değerlendirilmesi; Bir İnme Merkezinin Deneyimleri

Evaluation of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis; Experiences of a Stroke Center

INTRODUCTION: Intravenous thrombolytic (iv-tPA) treatment is a recommended treatment in acute ischemic stroke (AIS). We aimed to evaluate the effectiveness and side effects of this treatment on our patients. METHODS: We retrospectively evaluated the datas of patients with AIS treated with 0,9 mg/kg iv-tPA between 2018-2020. RESULTS: Forty-nine patients were treated with iv-tPA between 2018 and 2020. NIHSS scores at 24th hour were found significantly decreased compared with at onset(8,3±4,1 at onset, 4,9±5,1 at 24th hour, p=0,000). Thirty-eight (%77,6) patients had good clinical outcome. Intracerebral hemorrhage (ICH) was spotted in 3 (6,1%) patients. Systolic blood pressure (ICH group: 163±59 mmHg, non-ICH group: 141±25 mmHg p=0,014), serum glucose level(ICH group: 173±117 mg/dl, non-ICH group: 124±45mg/ dl, p=0,007) and mean door-needle time (ICH group: 125±9 min., non-ICH group: 137±54 min. p=0,029) were found significantly increased in patients with ICH. Total 4 (8,2%) patients died after iv-tPAtreatment. DISCUSSION AND CONCLUSION: Our study showed that iv-tPA improves the clinical findings of AIS. Additinally high serume glucose level and systolic blood pressure may increase the risk of ICH.

PDF

___

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al. Thrombolysis with alteplase 3 to 4,5 hours afteracuteischemicstroke.NEnglJMed2008;359(13):1317- 29.
3. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke AGuideline for Healthcare Professionals FromtheAmerican Heart Association/American Stroke Association. Stroke. 2018;49:e46–e99.
4. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al: Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534- 42.
5. Tan IY, Demchuk AM, Hopyan J, Zhang L, Gladstone D, Wong K et al. CTangiography clot burden score and collatera score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30:525-31.
6. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et-al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1): 35-41.
7. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation ofThrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275–82.
8. Ahmed N, Kellert L, Lees KR, Mikulik R, Tatlisumak T, Toni D et al. Results of Intravenous Thrombolysis Within 4.5 to6Hours and Updated Results Within 3 to 4.5 Hours of Onset ofAcute Ischemic StrokeRecorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study. JAMA Neurology 2013;70(7):837-44.
9. Kutluk K, Kaya D, Afsar N, Arsava EM, Ozturk V, Uzuner N et al. Turkish Thrombolysis Study Group. Analyses of the Turkish National Intravenous Thromboliysis Registry. J Stroke Cerebrovasc Dis 2016;25:1041-7.
10. Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC etal. American Hearth Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatmen. Stroke 2015;46(10):3020-35
11. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38(3):948–954.
12. Çabalar M, Taşdemir N, Erdoğan HA, Yayla V, Sözer N, Çağırıcı S et al.Akut İskemik İnmede İntravenöz Trombolitik Tedavi Deneyimlerimiz. Bakırkoy Tıp Dergisi 2018;14:71-5 doi: 10.5350/BTDMJB.20161221082709.
13. Kharitonova TV, Melo TP, Andersen G, Egido JA, Castillo J, Wahlgren N et al. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis. Stroke 2013;44:2513- 18. doi: 10.1161/STROKEAHA.111.000048.
14. Das S, Mondal GP, Bhattacharya R, Ghosh KC, Das S, Pattem HK et al.Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke. J Neurosci Rural Pract 2020 Apr;11(2):315-324. doi: 10.1055/s-0040-1709946.
15. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768–74
16. The NINDS t-PA Stroke Study Group. Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke. Stroke. 1997;28(11),:2109-18.
17. Nisar T, Hanumanthu R, Khandelwal P. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models. J Stroke Cerebrovas Dis. 2019;28(11):104360. doi: 10.1016/j. jstrokecerebrovasdis.2019.104360.
18. Mishiro K, Imai T, Sugitani S, et al. Diabetes mellitus aggravates hemorrhagic transformation after ischemicstroke via mitochondrialefects leading to endothelialapoptosis. PLoS One. 2014;9(8):e103818. doi: 10.1371/journal. pone.0103818.